Drugs News and Research

RSS

Researchers identify protein that interferes with the body's ability to get rid of 'bad' cholesterol

A team of researchers at the University of Alberta has uncovered a long-sought link in the battle to control cholesterol and heart disease.

1 Apr 2021

KHN’s ‘What the Health?’: Planning for round two

Congress is out of session, but that hasn't stopped Democrats from planning their next round of health legislation.

1 Apr 2021

Research finds possible explanation for why many cancer drugs don't work in human trials

A possible explanation for why many cancer drugs that kill tumor cells in mouse models won't work in human trials has been found by researchers with The University of Texas Health Science Center at Houston (UTHealth) School of Biomedical Informatics and McGovern Medical School.

1 Apr 2021

FDA investigates contributing factors for reported infections from reprocessed urological endoscopes

Today, the U.S. Food and Drug Administration announced it is investigating numerous medical device reports (MDRs) describing patient infections and other possible contamination issues associated with reprocessing urological endoscopes, including cystoscopes, ureteroscopes and cystourethroscopes—devices used to view and access the urinary tract.

1 Apr 2021

Single injection of RNA therapy improves vision in patient with genetic form of childhood blindness

A Penn Medicine patient with a genetic form of childhood blindness gained vision, which lasted more than a year, after receiving a single injection of an experimental RNA therapy into the eye.

1 Apr 2021

Could a flavonoid found in common fruit and vegetables combat COVID-19?

Researchers in India have gathered and presented a large body of evidence highlight quercetin – a flavonoid molecule found in many common fruits and vegetables – may be developed into drug therapies used to combat COVID-19.

1 Apr 2021

Targeting MCL-1 protein could pave way to new treatments for breast cancer

A protein frequently found in high levels in breast cancer cells helps tumours to survive and grow, and could be targeted with a new type of drug that is already being tested for other cancers, new research reveals.

1 Apr 2021

FDA takes action to advance OTC and other screening test development

Following recent U.S. Food and Drug Administration actions to support test development, the FDA took swift action this week to get more tests for screening asymptomatic individuals on the market. Today, the agency authorized several tests for over-the-counter (OTC) use without a prescription when used for serial screening.

1 Apr 2021

Temperature difference in the upper and lower respiratory tract influences SARS-CoV-2 replication

A team of researchers from the Institute for Infectious Diseases (IFIK) at the University of Bern and the Federal Institute of Virology and Immunology (IVI) have assessed virus growth and activation of the cellular defense mechanisms in the respiratory tract.

1 Apr 2021

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

The College of American Pathologists (CAP), in collaboration with five other societies, developed a draft evidence-based clinical practice guideline that aims to optimize PD-L1 testing for patients with non-small cell lung cancer (NSCLC) who are being considered for immunooncology therapy.

1 Apr 2021

Study sheds new light on the role of oxygen deprivation in cancer development

A team of University of Colorado School of Medicine researchers recently published a paper offering new insight into the role that oxygen deprivation, or hypoxia, plays in cancer development.

1 Apr 2021

Objectives, challenges and opportunities of new IASLC Molecular Database Project

A new Molecular Database Project initiated by the International Association for the Study of Lung will accelerate the understanding of lung cancer biology, clinical care and care delivery on a global scale and will improve the prognosis and optimal treatment of lung cancer across time and space, according to an editorial in the Journal of Thoracic Oncology, an official journal of the IASLC.

31 Mar 2021

Mice study points to a promising treatment for relieving colitis pain without side effects

A targeted opioid that only treats diseased tissues and spares healthy tissues relieves pain from inflammatory bowel disease without causing side effects, according to new research published in the journal Gut.

31 Mar 2021

Giving chemotherapy in the morning can extend survival of glioblastoma patients

An aggressive type of brain cancer, glioblastoma has no cure. Patients survive an average of 15 months after diagnosis, with fewer than 10% of patients surviving longer than five years.

31 Mar 2021

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

In a study recently published in the leading journal "Blood", Florian Moik and Cihan Ay from the Division of Hematology and Hemastasology of the Department of Medicine I of MedUni Vienna/Vienna General Hospital, working in collaboration with the Division of Oncology, the Department of Dermatology and the dispensary of Vienna General Hospital, provided preliminary data on the incidence, risk factors and clinical outcomes of thrombotic complications in this new form of cancer treatment.

31 Mar 2021

Obesity and ethnicity identified as key risk factors for SARS-CoV-2 exposure in UK

The risk factors for severe COVID-19 have been established on the basis of observational studies. However, SARS-CoV-2 continues to cause thousands of COVID-19 cases all over the world, and the risk factors are unclear. A new study deals with this aspect of the pandemic.

31 Mar 2021

Infliximab may hinder the effectiveness of some COVID-19 vaccines

A new study reports reduced vaccine efficacy following the use of a single COVID-19 vaccine dose in people who are on the immunosuppressive monoclonal antibody Infliximab.

31 Mar 2021

Key Milestone in Molded Glass: SGD Pharma Elevates Type I Offering with Three Tailored Product and Service Solutions

SGD Pharma, a leading supplier of glass primary packaging in the pharmaceutical industry and global expert in Type I molded glass, introduces an industry-first offering of Type I molded glass vials.

From SGD Pharma 31 Mar 2021

Early treatment with anti-VEGF injections slows diabetic retinopathy

Early treatment with anti-VEGF injections slowed diabetic retinopathy in a clinical study from the DRCR Retina Network (DRCR.net). However, two years into the four-year study its effect on vision was similar to standard treatment, which usually begins at the onset of late disease.

31 Mar 2021

Widely available drug reduces morbidity, mortality in COVID-19-infected mice

Mount Sinai researchers have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, the virus that causes COVID-19.

31 Mar 2021

Drugs News and Research

Researchers identify protein that interferes with the body's ability to get rid of 'bad' cholesterol

KHN’s ‘What the Health?’: Planning for round two

Research finds possible explanation for why many cancer drugs don't work in human trials

FDA investigates contributing factors for reported infections from reprocessed urological endoscopes

Single injection of RNA therapy improves vision in patient with genetic form of childhood blindness

Could a flavonoid found in common fruit and vegetables combat COVID-19?

Targeting MCL-1 protein could pave way to new treatments for breast cancer

FDA takes action to advance OTC and other screening test development

Temperature difference in the upper and lower respiratory tract influences SARS-CoV-2 replication

Evidence-based clinical practice guideline aims to optimize PD-L1 lung tumor testing

Study sheds new light on the role of oxygen deprivation in cancer development

Objectives, challenges and opportunities of new IASLC Molecular Database Project

Mice study points to a promising treatment for relieving colitis pain without side effects

Giving chemotherapy in the morning can extend survival of glioblastoma patients

Cancer patients treated with immunotherapy at high risk of developing thrombotic complications

Obesity and ethnicity identified as key risk factors for SARS-CoV-2 exposure in UK

Infliximab may hinder the effectiveness of some COVID-19 vaccines

Key Milestone in Molded Glass: SGD Pharma Elevates Type I Offering with Three Tailored Product and Service Solutions

Early treatment with anti-VEGF injections slows diabetic retinopathy

Widely available drug reduces morbidity, mortality in COVID-19-infected mice

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News